A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：43
|
作者：
Hong, Min Hee
Kim, HyeRyun
Park, Seong Yong
Kim, Dae Joon
Lee, Chang Geol
Cho, Jaeho
Kim, Jong Hoon
Kim, Hyeong Ryul
Kim, Yong-Hee
Park, Sook Ryun
Cho, Byoung Chul
机构：
[1] Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Thorac & Cardiovascular Surg, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Dept Radiat Oncol, Asan Med Ctr, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Dept Thorac & Cardiovasular Surg, Asan Med Ctr, Seoul, South Korea
[6] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4027
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)
    Lee, S.
    Ahn, B. C.
    Park, S. Y.
    Kim, D. J.
    Lee, C. G.
    Cho, J.
    Kim, J. H.
    Kim, H. R.
    Kim, Y-H.
    Park, S. R.
    Chun, Y. J.
    Hong, M. H.
    Kim, H. R.
    Cho, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Preoperative pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma (ESCC): The phase II Keystone-001 trial
    Jiang, H.
    Shang, X.
    Xie, Y.
    Zhao, G.
    Zhang, C.
    Zhang, W.
    Liu, L.
    Li, R.
    Yue, J.
    Chen, C.
    Duan, X.
    Ma, Z.
    Sun, Y.
    Yu, J.
    Ren, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S872 - S873
  • [3] Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design
    Zheng, Yuyan
    Li, Chengqiang
    Yu, Bentong
    Zhao, Shengguang
    Li, Jian
    Chen, Xiaoyan
    Li, Hecheng
    JTCVS OPEN, 2022, 9 : 293 - 299
  • [4] Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
    Li, Hui
    Gu, Dayong
    Du, Mingyu
    Zhou, Guoren
    Zhang, Zhi
    Ye, Jinjun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Nimotuzumab in combination with preoperative concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A prospective trial
    Wu, Xiaoyuan
    Chen, Yongshun
    Yang, Yuanyuan
    Hao, Daxuan
    Li, Xue
    He, Chunyu
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Nobuhiro Tsuchiya
    Chikara Kunisaki
    Sho Sato
    Yusaku Tanaka
    Kei Sato
    Jun Watanabe
    Kazuhisa Takeda
    Takashi Kosaka
    Hirotoshi Akiyama
    Itaru Endo
    Langenbeck's Archives of Surgery, 2022, 407 : 1911 - 1921
  • [8] Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Tsuchiya, Nobuhiro
    Kunisaki, Chikara
    Sato, Sho
    Tanaka, Yusaku
    Sato, Kei
    Watanabe, Jun
    Takeda, Kazuhisa
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Endo, Itaru
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (05) : 1911 - 1921
  • [9] Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
    Hiroyuki Harada
    Ken Omura
    Hirofumi Tomioka
    Hideki Nakayama
    Akimitsu Hiraki
    Masanori Shinohara
    Yasuto Yoshihama
    Satoru Shintani
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1059 - 1064
  • [10] Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
    Harada, Hiroyuki
    Omura, Ken
    Tomioka, Hirofumi
    Nakayama, Hideki
    Hiraki, Akimitsu
    Shinohara, Masanori
    Yoshihama, Yasuto
    Shintani, Satoru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1059 - 1064
12345